4.4 Article

Long-term safety, efficacy, and tolerability of levetiracetam in pediatric patients with epilepsy in Uygur, China: A retrospective analysis

Related references

Note: Only part of the references are listed.
Article Behavioral Sciences

Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China

Ting Zhao et al.

Summary: The study demonstrated that lacosamide therapy is effective and safe for pediatric epilepsy patients in the Uygur region of China, leading to a reduction in seizure rates. However, around one-third of children may experience adverse reactions during treatment.

EPILEPSY & BEHAVIOR (2021)

Article Pharmacology & Pharmacy

Efficacy and safety of levetiracetam in Japanese epilepsy patients: A retrospective cohort study

Hiromi Sekimoto et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)

Review Medicine, General & Internal

Epilepsy in Children: From Diagnosis to Treatment with Focus on Emergency

Carmelo Minardi et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Review Clinical Neurology

The economic impact of epilepsy: a systematic review

Katharina Allers et al.

BMC NEUROLOGY (2015)

Editorial Material Clinical Neurology

Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly

J. Fattouch et al.

ACTA NEUROLOGICA SCANDINAVICA (2010)

Article Pediatrics

Levetiracetam in Childhood Epilepsy

Alberto Verrotti et al.

PEDIATRIC DRUGS (2010)

Article Clinical Neurology

Levetiracetam in absence epilepsy

Alberto Verrotti et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2008)

Article Clinical Neurology

Use of levetiracetam in treating epilepsy associated with other medical conditions

C Di Bonaventura et al.

ACTA NEUROLOGICA SCANDINAVICA (2006)

Review Pharmacology & Pharmacy

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

PN Patsalos

PHARMACOLOGY & THERAPEUTICS (2000)